179 related articles for article (PubMed ID: 36867423)
1. The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review.
Ramessar N; Borad A; Schlesinger N
Lupus; 2023 Apr; 32(5):644-657. PubMed ID: 36867423
[TBL] [Abstract][Full Text] [Related]
2. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study.
Khajehdehi P; Zanjaninejad B; Aflaki E; Nazarinia M; Azad F; Malekmakan L; Dehghanzadeh GR
J Ren Nutr; 2012 Jan; 22(1):50-7. PubMed ID: 21742514
[TBL] [Abstract][Full Text] [Related]
3. Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome.
Zhao J; Wang J; Zhou M; Li M; Li M; Tan H
Int Immunopharmacol; 2019 Apr; 69():213-216. PubMed ID: 30738291
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
Dehzad MJ; Ghalandari H; Nouri M; Askarpour M
Cytokine; 2023 Apr; 164():156144. PubMed ID: 36804260
[TBL] [Abstract][Full Text] [Related]
6. The effect of Omega-3 fatty acid supplementation in systemic lupus erythematosus patients: A systematic review.
Ramessar N; Borad A; Schlesinger N
Lupus; 2022 Mar; 31(3):287-296. PubMed ID: 35023407
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
Liu S; Guo YL; Yang JY; Wang W; Xu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
[TBL] [Abstract][Full Text] [Related]
8. The Use of Curcumin for the Treatment of Renal Disorders: A Systematic Review of Randomized Controlled Trials.
Bagherniya M; Soleimani D; Rouhani MH; Askari G; Sathyapalan T; Sahebkar A
Adv Exp Med Biol; 2021; 1291():327-343. PubMed ID: 34331699
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of oral supplementation with curcumin: a systematic review and meta-analysis of randomized controlled trials.
Ferguson JJA; Abbott KA; Garg ML
Nutr Rev; 2021 Aug; 79(9):1043-1066. PubMed ID: 34378053
[TBL] [Abstract][Full Text] [Related]
10. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus.
Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X
Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258
[TBL] [Abstract][Full Text] [Related]
11. Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.
Shemer A; Kivity S; Shovman O; Bashi T; Perry O; Watad A; Ben-Ami Shor D; Volkov A; Barshack I; Bragazzi NL; Krule A; Fridkin M; Amital H; Blank M; Shoenfeld Y
Clin Exp Immunol; 2018 Aug; 193(2):160-166. PubMed ID: 29698559
[TBL] [Abstract][Full Text] [Related]
12. Diet and Systemic Lupus Erythematosus (SLE): From Supplementation to Intervention.
Jiao H; Acar G; Robinson GA; Ciurtin C; Jury EC; Kalea AZ
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231195
[TBL] [Abstract][Full Text] [Related]
13. Low-Molecular-Weight Heparin Enhanced Therapeutic Effects of Human Adipose-Derived Stem Cell Administration in a Mouse Model of Lupus Nephritis.
Matsuda S; Kotani T; Saito T; Suzuka T; Mori T; Takeuchi T
Front Immunol; 2021; 12():792739. PubMed ID: 35095868
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
15. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
Igarashi T; Igarashi T; Shimizu A; Itoh Y
J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis.
Friebus-Kardash J; Trendelenburg M; Eisenberger U; Ribi C; Chizzolini C; Huynh-Do U; Lang KS; Wilde B; Kribben A; Witzke O; Dolff S; Hardt C
BMC Nephrol; 2019 Nov; 20(1):430. PubMed ID: 31752784
[TBL] [Abstract][Full Text] [Related]
17. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
Li X; Wang M; Hong H; Luo C; Liu Z; Yang R
Immunol Res; 2018 Aug; 66(4):521-527. PubMed ID: 30047025
[TBL] [Abstract][Full Text] [Related]
18. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
[TBL] [Abstract][Full Text] [Related]
19. Belimumab: review of use in systemic lupus erythematosus.
Boyce EG; Fusco BE
Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
[TBL] [Abstract][Full Text] [Related]
20. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
